1-16024780-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004070.4(CLCNKA):​c.247A>G​(p.Arg83Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.562 in 1,613,634 control chromosomes in the GnomAD database, including 257,855 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R83K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.59 ( 27334 hom., cov: 32)
Exomes 𝑓: 0.56 ( 230521 hom. )

Consequence

CLCNKA
NM_004070.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.107

Publications

45 publications found
Variant links:
Genes affected
CLCNKA (HGNC:2026): (chloride voltage-gated channel Ka) This gene is a member of the CLC family of voltage-gated chloride channels. The encoded protein is predicted to have 12 transmembrane domains, and requires a beta subunit called barttin to form a functional channel. It is thought to function in salt reabsorption in the kidney and potassium recycling in the inner ear. The gene is highly similar to CLCNKB, which is located 10 kb downstream from this gene. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CLCNKA Gene-Disease associations (from GenCC):
  • Bartter disease type 4B
    Inheritance: Unknown, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • Bartter syndrome type 4
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.8806211E-6).
BP6
Variant 1-16024780-A-G is Benign according to our data. Variant chr1-16024780-A-G is described in ClinVar as Benign. ClinVar VariationId is 585697.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.76 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CLCNKANM_004070.4 linkc.247A>G p.Arg83Gly missense_variant Exon 4 of 20 ENST00000331433.5 NP_004061.3 P51800-1
CLCNKANM_001042704.2 linkc.247A>G p.Arg83Gly missense_variant Exon 4 of 20 NP_001036169.1 P51800-3
CLCNKANM_001257139.2 linkc.229+852A>G intron_variant Intron 3 of 18 NP_001244068.1 P51800-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CLCNKAENST00000331433.5 linkc.247A>G p.Arg83Gly missense_variant Exon 4 of 20 1 NM_004070.4 ENSP00000332771.4 P51800-1

Frequencies

GnomAD3 genomes
AF:
0.592
AC:
89861
AN:
151908
Hom.:
27307
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.703
Gnomad AMI
AF:
0.381
Gnomad AMR
AF:
0.471
Gnomad ASJ
AF:
0.455
Gnomad EAS
AF:
0.780
Gnomad SAS
AF:
0.571
Gnomad FIN
AF:
0.510
Gnomad MID
AF:
0.637
Gnomad NFE
AF:
0.560
Gnomad OTH
AF:
0.600
GnomAD2 exomes
AF:
0.551
AC:
138274
AN:
251076
AF XY:
0.553
show subpopulations
Gnomad AFR exome
AF:
0.705
Gnomad AMR exome
AF:
0.380
Gnomad ASJ exome
AF:
0.464
Gnomad EAS exome
AF:
0.757
Gnomad FIN exome
AF:
0.522
Gnomad NFE exome
AF:
0.560
Gnomad OTH exome
AF:
0.545
GnomAD4 exome
AF:
0.559
AC:
816601
AN:
1461608
Hom.:
230521
Cov.:
60
AF XY:
0.559
AC XY:
406144
AN XY:
727106
show subpopulations
African (AFR)
AF:
0.714
AC:
23912
AN:
33472
American (AMR)
AF:
0.391
AC:
17478
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.467
AC:
12192
AN:
26124
East Asian (EAS)
AF:
0.737
AC:
29243
AN:
39696
South Asian (SAS)
AF:
0.551
AC:
47497
AN:
86252
European-Finnish (FIN)
AF:
0.522
AC:
27842
AN:
53322
Middle Eastern (MID)
AF:
0.550
AC:
3170
AN:
5764
European-Non Finnish (NFE)
AF:
0.558
AC:
620622
AN:
1111878
Other (OTH)
AF:
0.574
AC:
34645
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
20995
41991
62986
83982
104977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17456
34912
52368
69824
87280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.592
AC:
89927
AN:
152026
Hom.:
27334
Cov.:
32
AF XY:
0.584
AC XY:
43408
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.703
AC:
29171
AN:
41478
American (AMR)
AF:
0.470
AC:
7185
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.455
AC:
1579
AN:
3468
East Asian (EAS)
AF:
0.780
AC:
4026
AN:
5162
South Asian (SAS)
AF:
0.571
AC:
2743
AN:
4806
European-Finnish (FIN)
AF:
0.510
AC:
5393
AN:
10572
Middle Eastern (MID)
AF:
0.637
AC:
186
AN:
292
European-Non Finnish (NFE)
AF:
0.560
AC:
38030
AN:
67950
Other (OTH)
AF:
0.599
AC:
1267
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1823
3646
5468
7291
9114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
742
1484
2226
2968
3710
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.569
Hom.:
10775
Bravo
AF:
0.591
TwinsUK
AF:
0.564
AC:
2092
ALSPAC
AF:
0.551
AC:
2124
ESP6500AA
AF:
0.696
AC:
3067
ESP6500EA
AF:
0.552
AC:
4748
ExAC
AF:
0.563
AC:
68366
Asia WGS
AF:
0.631
AC:
2195
AN:
3478
EpiCase
AF:
0.553
EpiControl
AF:
0.559

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

May 07, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23850580, 21248228) -

Bartter disease type 4B Benign:2
Jul 22, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 28, 2019
Mendelics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 16, 2021
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.43
CADD
Benign
9.0
DANN
Benign
0.89
DEOGEN2
Benign
0.086
.;T
Eigen
Benign
-0.93
Eigen_PC
Benign
-0.84
FATHMM_MKL
Benign
0.20
N
LIST_S2
Benign
0.26
T;T
MetaRNN
Benign
0.0000019
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
0.11
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.17
N;N
REVEL
Benign
0.23
Sift
Benign
0.39
T;T
Sift4G
Benign
0.52
T;T
Polyphen
0.0
.;B
Vest4
0.095
MPC
0.45
ClinPred
0.0049
T
GERP RS
0.87
Varity_R
0.061
gMVP
0.33
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10927887; hg19: chr1-16351275; COSMIC: COSV58890913; COSMIC: COSV58890913; API